Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, France.
Autoimmun Rev. 2017 Apr;16(4):416-426. doi: 10.1016/j.autrev.2017.02.013. Epub 2017 Feb 14.
Inflammatory molecules play a crucial role in the pathogenesis of inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn's disease, both of which are chronic inflammatory conditions of the gastrointestinal tract. Abnormal expressions of pro- and anti-inflammatory molecules have been described to cause an imbalance to the gut innate and adaptive immunity, and recently a large portion of research in IBD has been geared towards identifying novel molecules that may be used as potential therapeutic targets. Understanding of these inflammatory molecules has suggested that although ulcerative colitis and Crohn's disease share many common clinical symptoms and signs, they are in fact two separate clinical entities characterized by different immunopathogenesis. In this review, we comprehensively discuss the roles of numerous inflammatory molecules including but not limited to cytokines, chemokines, inflammasomes, microRNAs and neuropeptides and their expression status in ulcerative colitis and Crohn's disease in relation to their effects on the overall intestinal inflammatory process.
炎症分子在炎症性肠病(IBD)的发病机制中起着至关重要的作用,例如溃疡性结肠炎和克罗恩病,这两种疾病都是胃肠道的慢性炎症性疾病。已经描述了促炎和抗炎分子的异常表达会导致肠道先天和适应性免疫失衡,最近,IBD 的大部分研究都致力于确定可能用作潜在治疗靶点的新型分子。对这些炎症分子的理解表明,尽管溃疡性结肠炎和克罗恩病具有许多共同的临床症状和体征,但实际上它们是两种不同的临床实体,其免疫发病机制不同。在这篇综述中,我们全面讨论了许多炎症分子的作用,包括但不限于细胞因子、趋化因子、炎性小体、microRNAs 和神经肽及其在溃疡性结肠炎和克罗恩病中的表达状态,以及它们对整个肠道炎症过程的影响。